Federal heat on UnitedHealth sends shares tumbling — what you need to know
UnitedHealth DOJ probe impacts stock value as federal heat intensifies on the healthcare giant. The U.S. Justice Department has launched both criminal and civil investigations into UnitedHealth's Medicare Advantage billing practices, raising serious concerns about possible overcharging. As news broke, UnitedHealth's stock plunged over 4%, deepening a year-long 40% decline. Investors are now worried about future earnings, rising healthcare costs, and tighter regulations. UnitedHealth says it's cooperating fully and reviewing its billing system. With leadership changes and legal pressure mounting, this story is a must-read for anyone watching the healthcare or stock market space right now.
UnitedHealth Group (NYSE: UNH) stock has lost over 40% of its value in 2025, wiping out more than $120 billion in market capitalization. The latest blow came after the healthcare giant confirmed it is under criminal and civil investigation by the U.S. Department of Justice (DOJ) over its Medicare Advantage billing practices, sending shares tumbling nearly 4% in pre-market trading. With rising medical costs, shaken investor confidence, and leadership upheaval, UnitedHealth's dramatic decline marks one of the worst performances among S&P 500 stocks this year. UnitedHealth Group Inc. (NYSE: UNH) saw its stock tumble nearly 4% today, continuing a steep downward spiral that has erased over 40% of its value in 2025 alone. The latest drop comes after the company confirmed that it's under both criminal and civil investigation by the U.S. Department of Justice (DOJ), related to its Medicare Advantage billing practices. UnitedHealth stock has been among the worst performers on the S&P 500 this year. After starting 2025 near $525 per share, the stock has plummeted below $300, marking a more than 40% year-to-date drop.
Key moments behind the plunge: April 2025 : Stock dropped 22% in a single day after missing Q1 earnings and slashing full-year guidance.
: Stock dropped after missing Q1 earnings and slashing full-year guidance. May 2025 : CEO Andrew Witty resigned, adding leadership instability to the mix.
: CEO Andrew Witty resigned, adding leadership instability to the mix. July 2025: Confirmation of DOJ investigation triggers renewed selling pressure.
The Department of Justice (DOJ) is officially investigating UnitedHealth Group—America's largest health insurer—over its Medicare Advantage billing. The federal probes focus on whether the company artificially inflated patient risk scores to receive higher reimbursements from the government. UnitedHealth has confirmed receiving requests for information from the DOJ and stated it is cooperating fully with both criminal and civil investigations. While the company initially denied any criminal probe, it now admits it had proactively reached out to federal authorities earlier this year to clarify billing procedures and launch internal reviews.
The DOJ's primary concern is centered on risk adjustment coding—a process that determines how much money the federal government pays insurers like UnitedHealth based on patients' medical conditions. Allegations suggest the company may have exaggerated diagnoses to collect excess payments from Medicare.
As soon as news of the investigation surfaced, UnitedHealth stock took a hit. Shares fell over 4% in premarket trading, extending a broader decline that's seen the stock drop more than 40% year-to-date.
This is not an isolated event. Earlier this year, UnitedHealth's stock experienced a major downturn when its former CEO unexpectedly resigned and the company withdrew its 2025 earnings guidance, citing cost overruns tied to its Medicare Advantage business. The current legal troubles are piling onto existing financial pressures, sending a clear message to investors: the road ahead may be rocky. At the heart of the investigation is Medicare Advantage, a privately managed health insurance program funded by the federal government. Insurers like UnitedHealth receive payments based on the health risk profiles of their enrollees. The more serious the health conditions of a patient, the higher the risk score—and the larger the government payout. However, the DOJ is now investigating whether UnitedHealth manipulated these scores by inflating patient diagnoses. This isn't a new concern in the industry. Other insurers have faced similar audits and lawsuits. However, given UnitedHealth's size and influence, the implications could be significantly larger. This is the big question facing investors. UNH stock may look cheap relative to historical valuation, but headline risk remains high. Here are two opposing scenarios:
Bull Case: DOJ investigation ends with a manageable settlement.
Medical cost inflation stabilizes.
Leadership transition brings strategic clarity. Bear Case: Legal issues expand and trigger major fines or contract losses.
Costs continue rising, forcing more earnings cuts.
Institutional investors exit further, adding pressure.
In response to the federal heat, UnitedHealth has taken several steps to present itself as compliant and transparent: Voluntary Disclosures : The company claims it initiated contact with the DOJ months ago and is cooperating with all requests.
: The company claims it initiated contact with the DOJ months ago and is cooperating with all requests. Third-party Audits : UnitedHealth says it is conducting external reviews of its risk adjustment processes, possibly signaling internal reforms are underway.
: UnitedHealth says it is conducting external reviews of its risk adjustment processes, possibly signaling internal reforms are underway. Compliance Enhancements: The insurer is working on strengthening its internal controls to ensure billing accuracy going forward. Despite these efforts, legal experts suggest that even if no wrongdoing is found, the very existence of a federal investigation could lead to increased regulatory oversight, reputational damage, and mounting legal expenses. The DOJ probe comes at a time when UnitedHealth is already navigating several internal and external challenges: In May, longtime CEO Andrew Witty stepped down unexpectedly amid the growing storm. Former CEO Stephen Hemsley returned to stabilize the company and restore investor trust. Healthcare utilization surged in recent quarters, leading to higher-than-expected medical costs. UnitedHealth has warned of increased pressure on margins due to greater demand for surgeries, outpatient care, and chronic condition treatments. Alongside regulatory attention, UnitedHealth is facing public scrutiny. If the DOJ finds grounds for prosecution, the company could face heavy fines, tighter compliance mandates, or even restrictions on future government contracts. For investors, the combination of legal risk, leadership uncertainty, and financial strain creates a complex risk profile. Shareholder Value : With shares down over 40% YTD, portfolio exposure is already taking a hit.
: With shares down over 40% YTD, portfolio exposure is already taking a hit. Earnings Outlook : With the company pulling its 2025 forecast, investors are left without clarity on future earnings potential.
: With the company pulling its 2025 forecast, investors are left without clarity on future earnings potential. Regulatory Uncertainty: Prolonged investigations may drag down sentiment and stock performance even if no wrongdoing is proven. While some see the current dip as a buying opportunity in a fundamentally strong company, others warn that further volatility is likely in the coming quarters. Earnings Report (Early August) : Investors are eagerly awaiting the next quarterly results. The focus will be on legal disclosures, medical cost trends, and updated guidance.
: Investors are eagerly awaiting the next quarterly results. The focus will be on legal disclosures, medical cost trends, and updated guidance. DOJ Progress Updates : Any new details about the investigation's scope, possible subpoenas, or charges could further affect stock movement.
: Any new details about the investigation's scope, possible subpoenas, or charges could further affect stock movement. Organizational Changes: Investors will also watch for more leadership reshuffles or board-level changes aimed at regaining market trust. The UnitedHealth DOJ investigation is a serious matter—not just for the company, but for the broader health insurance industry. While the company has made moves toward transparency and reform, the federal probe introduces significant uncertainty around both earnings and regulatory compliance. If you're an investor, this is a moment to remain informed and cautious. Watching how the company navigates the legal, financial, and reputational fallout will be critical in determining whether UnitedHealth can regain its footing—or if deeper troubles lie ahead.
Q1: Why is UnitedHealth under DOJ investigation? The DOJ is probing UnitedHealth for possibly overbilling Medicare Advantage through inflated diagnoses.
Q2: How did the DOJ probe affect UnitedHealth stock? UnitedHealth stock fell sharply after the DOJ launched its criminal and civil investigations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Fed rate cuts are coming — here's how much the stock market could boom based on history
S&P 500 Has Historically Surged After Fed's Interest Rate Cuts Biggest Bull Markets Often Follow Fed Easing Cycles Fed Rate Cuts Don't Always Guarantee Stock Gains Live Events Trade War and Tariffs Could Undermine Fed's Impact Wall Street Divided on Whether Fed Will Cut Rates in 2025 Best Stock Sectors to Watch During Rate-Cut Cycles FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel After months of weak job growth, investors are looking to thewith growing anticipation, as many are expecting the central bank to cut interest rates at its September meeting, and if history repeats itself, that could be a big win for the stock market, as per a to a new analysis from LPL Financial, thehas historically performed well during rate-cutting cycles, as reported by Business Insider. Since 1974, the index has gained an average of 30.3% from the first rate cut until the beginning of the next rate-hiking cycle, according to the report. The median return in those periods was 13.3%, with stocks finishing higher in six out of nine cases, as per Business Buchbinder, LPL's chief equity strategist, said that, "Using history and prior Fed cutting cycles as a guide, some upside potential may remain for the second half of 2025," adding, "But of course, past performance does not guarantee future results, and a new tariff regime not seen since the 1930s could slow earnings growth and fuel volatility," as quoted in the READ: The hidden recession: Job cuts, housing freeze, and fear grip US economy behind the AI boom and surging Wall Street Some of the most significant gains in stock market history followed periods of falling interest rates. The S&P 500 surged 161% from 1995 to 1999 in the lead-up to the dot-com bubble, reported Business Insider. Other notable rallies include a 62.8% gain from 1984 to 1993 and a 38.2% rise from 2019 to 2021, according to the not all rate-cutting cycles have gone smoothly. During the 2007 to 2009 financial crisis, the market dropped 23.5% despite rate reductions. Similarly, between 2001 and 2004, the S&P 500 fell 9.6%, proving that timing and context matter, as per Business READ: Japan's population plunges by 900,000 in just 1 year — worst drop in modern history as birth rates hit crisis point This time around, there are new challenges. The stock market has already climbed more than 12% since the Fed's first cut last September, fueled largely by excitement around artificial intelligence and strong tech earnings, according to the pointed out that "The delayed effects of trade policy are likely to weigh on the economy in the second half, leading to weaker labor market demand," adding, "Recent market complacency toward trade policy and an economic narrative dependent upon strong economic data has caught our attention in recent weeks as a potential point of weakness," as quoted by Business investors are betting heavily on a September rate cut, with CME FedWatch showing over 93% odds, major institutions like Morgan Stanley and Bank of America believe the Fed may hold rates steady for the rest of 2025, according to the these mixed signals, Buchbinder recommends a cautious approach. He believes it's too early to increase portfolio risk beyond benchmark levels and suggests focusing on large-cap growth stocks, along with financials and communication services, as reported by Business said, "Bottom line, investors may be well served by bracing for occasional bouts of volatility given how much optimism is currently reflected in equity prices," as quoted in the short-term strategy team is also closely monitoring tariff negotiations, inflation data, bond yields, and earnings results for signs of a better entry point to add exposure to equities, according to Business rate cuts have led to big gains in the stock market, especially in the months following the first cut, as per the Business Insider are as CME data shows a 93% chance. But big banks like Morgan Stanley think the Fed may wait.
Time of India
an hour ago
- Time of India
IPOs in US Stock Market: Figma, stablecoin giant Circle raise the bar as newly public stocks fare against S&P 500
A surge in equity markets and robust debuts from notable newcomers have fueled renewed enthusiasm for initial public offerings. Design software maker Figma and stablecoin giant Circle peaked at 333 per cent and 864 per cent above their IPO prices in the days following their debut, highlighting how eager investors are to get behind the companies they think are future winners. Here's how an ETF tracking major newly public stocks has fared against the benchmark S&P 500 over the past year: Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Below is a look at how some of the biggest IPOs in recent years have performed: FIREFLY AEROSPACE: The Northrop Grumman-backed space tech firm Live Events upsized its IPO and priced above range to raise $868.3 million. Its stock opened nearly 56% above the IPO price on the Nasdaq. FIGMA: Design software maker Figma raised $1.22 billion in its IPO and ended its first day on the NYSE with an eye-popping gain of 250% in July. Its shares are now trading about 6% higher than where they opened, and 174% higher than the IPO price. CHIME: The financial technology company priced its IPO above the marketed range, raising $864 million in June. The stock opened 59% higher on debut and is now trading nearly 22% above the IPO price. CIRCLE INTERNET: The stablecoin issuer raised $1.05 billion in an upsized IPO earlier in June, debuting with a valuation of nearly $18 billion on a fully diluted basis. Its shares more than doubled on day one, closing about 168% above the IPO price. The stock is trading 134% above its price at open. ETORO: Robinhood-rival eToro secured a valuation of $5.64 billion after its shares surged 34% in their Nasdaq debut in May. The stock and cryptocurrency trading platform raised $620 million in an upsized IPO. Its stock has declined 19% since the debut. COREWEAVE: The AI cloud firm's Nasdaq debut was muted in March, but the stock has jumped nearly three-fold despite opening nearly 3% below its offer price. The Nvidia-backed company raised about $1.5 billion in its IPO for a valuation of about $23 billion on a fully diluted basis. VENTURE GLOBAL LNG: The liquefied natural gas exporter raised $1.75 billion in its offering in January, settling for nearly half the valuation it had aimed for earlier. The company's shares opened nearly 4% below their IPO price in a subdued NYSE debut. They have plunged around 40% since then. SAILPOINT: The Thoma Bravo-backed identity security company's shares traded flat in their Nasdaq debut, valuing it at $12.8 billion. The stock has since lost nearly 12%. The Austin, Texas-based company raised $1.38 billion in an upsized IPO. ARM HOLDINGS: The chip designer raised $4.87 billion in its offering in September 2023, valuing it at $54.5 billion. It had sought a valuation of as much as $52 billion. The company's shares rose 10% at the open. The stock has more than doubled since then. INSTACART: The San Francisco-based company, which is incorporated as Maplebear, was priced at the top end of the marketed range in its IPO. It raised $660 million at a nearly $9.9 billion valuation in September 2023. It had hiked its proposed price range and targeted a valuation of up to $10 billion. The grocery delivery app's stock popped 40% at the open and has since gained about 14%. VIKING HOLDINGS: The cruise operator's IPO raised $1.54 billion in April last year, valuing it at $10.35 billion. It had sought a valuation of as much as $10.8 billion in the offering. Viking's shares opened 9% above their offer price and have more than doubled since. STANDARDAERO: The aircraft maintenance services provider notched a valuation of roughly $8 billion after pricing its offering above range to raise $1.44 billion in October last year. It had initially targeted a valuation of up to $7.69 billion. The Carlyle-backed company's shares began trading 29% above the offer price. They have since lost around 9%. LINEAGE: The cold storage real estate investment trust raised $4.45 billion in its listing in July 2024, at a valuation of more than $18 billion. It had aimed for a valuation as high as $19.16 billion. The company's stock gained 5% in its Nasdaq debut at the open. However, it has fallen 46% below its price at open. REDDIT: The social media giant fetched $748 million in its IPO in March last year, which valued it at $6.4 billion — the top end of the target range at which it had advertised. Its stock opened 38% above the offer price, and has jumped more than four-fold since. BIRKENSTOCK: The 250-year-old German sandal maker raised $1.48 billion and was valued at $9.3 billion in its IPO in October 2023, slightly lower than its target of $10 billion. Its shares debuted 11% below their IPO price but have risen 20% since. FAQs Q1. How has Figma IPO performed? A1. Figma IPO peaked at 333 per cent above their IPO prices in the days following their debut. Q2. How has Circle IPO performed? A2. Stablecoin giant Circle peaked 864 per cent above their IPO prices.
Time of India
an hour ago
- Time of India
Fed rate cuts are coming — here's how much the stock market could boom based on history
US stock market reaction to Fed rate cuts : After months of weak job growth, investors are looking to the Federal Reserve with growing anticipation, as many are expecting the central bank to cut interest rates at its September meeting, and if history repeats itself, that could be a big win for the stock market, as per a report. S&P 500 Has Historically Surged After Fed's Interest Rate Cuts According to a new analysis from LPL Financial, the S&P 500 has historically performed well during rate-cutting cycles, as reported by Business Insider. Since 1974, the index has gained an average of 30.3% from the first rate cut until the beginning of the next rate-hiking cycle, according to the report. The median return in those periods was 13.3%, with stocks finishing higher in six out of nine cases, as per Business Insider. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Jeff Buchbinder, LPL's chief equity strategist, said that, "Using history and prior Fed cutting cycles as a guide, some upside potential may remain for the second half of 2025," adding, "But of course, past performance does not guarantee future results, and a new tariff regime not seen since the 1930s could slow earnings growth and fuel volatility," as quoted in the report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Here's The Estimated Cost of a 1-day Gutter Guards Installation HomeBuddy Click Here ALSO READ: The hidden recession: Job cuts, housing freeze, and fear grip US economy behind the AI boom and surging Wall Street Biggest Bull Markets Often Follow Fed Easing Cycles Some of the most significant gains in stock market history followed periods of falling interest rates. The S&P 500 surged 161% from 1995 to 1999 in the lead-up to the dot-com bubble, reported Business Insider. Other notable rallies include a 62.8% gain from 1984 to 1993 and a 38.2% rise from 2019 to 2021, according to the report. Fed Rate Cuts Don't Always Guarantee Stock Gains Still, not all rate-cutting cycles have gone smoothly. During the 2007 to 2009 financial crisis, the market dropped 23.5% despite rate reductions. Similarly, between 2001 and 2004, the S&P 500 fell 9.6%, proving that timing and context matter, as per Business Insider. Live Events ALSO READ: Japan's population plunges by 900,000 in just 1 year — worst drop in modern history as birth rates hit crisis point Trade War and Tariffs Could Undermine Fed's Impact This time around, there are new challenges. The stock market has already climbed more than 12% since the Fed's first cut last September, fueled largely by excitement around artificial intelligence and strong tech earnings, according to the report. Buchbinder pointed out that "The delayed effects of trade policy are likely to weigh on the economy in the second half, leading to weaker labor market demand," adding, "Recent market complacency toward trade policy and an economic narrative dependent upon strong economic data has caught our attention in recent weeks as a potential point of weakness," as quoted by Business Insider. Wall Street Divided on Whether Fed Will Cut Rates in 2025 While investors are betting heavily on a September rate cut, with CME FedWatch showing over 93% odds, major institutions like Morgan Stanley and Bank of America believe the Fed may hold rates steady for the rest of 2025, according to the report. Best Stock Sectors to Watch During Rate-Cut Cycles Given these mixed signals, Buchbinder recommends a cautious approach. He believes it's too early to increase portfolio risk beyond benchmark levels and suggests focusing on large-cap growth stocks, along with financials and communication services, as reported by Business Insider. He said, "Bottom line, investors may be well served by bracing for occasional bouts of volatility given how much optimism is currently reflected in equity prices," as quoted in the report. LPL's short-term strategy team is also closely monitoring tariff negotiations, inflation data, bond yields, and earnings results for signs of a better entry point to add exposure to equities, according to Business Insider. FAQs How do rate cuts usually affect the stock market? Historically, rate cuts have led to big gains in the stock market, especially in the months following the first cut, as per the Business Insider report. Are all investors expecting a rate cut? Most are as CME data shows a 93% chance. But big banks like Morgan Stanley think the Fed may wait.
